Breast cancer has truly made a name for itself as the most commonly diagnosed cancer, and the second most common cause of cancer death in women.1 About 1 in 8 U.S. women (about 12%) will develop invasive breast cancer over the course of her lifetime.1 In 2019, an estimated 268,600 new cases of invasive breast cancer are expected to be diagnosed in women in the U.S., along with 62,930 new cases of non-invasive (in situ) breast cancer.1
However, there are significant disparities in utilization of evidence-based breast cancer care among patients with different proportions of reimbursement. Patients with lower rate of reimbursement were less likely to receive recommended care.2
"In women with invasive breast cancer, does low reimbursement compared to high reimbursements, affect quality of care.,"
Lynchburg Journal of Medical Science: Vol. 1
, Article 28.
Available at: https://digitalshowcase.lynchburg.edu/dmscjournal/vol1/iss4/28
Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.
Off-campus users can also use 'Off-campus Download' button above for access.